Balyasny Asset Management L.P.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1218710
Chicago, IL
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,344,955
-$16,636,905 QoQ
Shares Held
1,054,613
-22.6% QoQ
Ownership
0.545%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#33
of 561 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Dec 31, 2025CallValue
$540,813
CallShares
9,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. BMRN ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
1,054,613 | $60,344,955 |
All Filings in BMRN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,344,955 | 1,054,613 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $76,981,860 | 1,362,752 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $540,813 | 9,100 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $13,693,002 | 252,825 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,225,279 | 440,700 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $547,635 | 7,747 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,157,780 | 337,103 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,514,500 | 50,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $64,007,198 | 910,616 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $84,264,096 | 1,023,492 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,671,299 | 20,300 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $559,844 | 6,800 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $20,694,776 | 236,945 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,642,000 | 100,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $40,936,942 | 424,569 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $80,551,838 | 910,396 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,101,079 | 116,533 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $29,767,496 | 306,124 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $21,484,936 | 207,604 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $66,611,248 | 785,788 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $46,796,522 | 564,698 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $1,453,335 | 18,850 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $1,484,300 | 19,657 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,647,570 | 53,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $14,329,335 | 163,409 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,783,082 | 36,581 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $13,175,918 | 106,826 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $12,334,000 | 100,000 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $30,951,674 | 366,292 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||